A recent decision by the US Supreme Court may lead to increased legal action within the healthcare sector, says one expert. Federal Trade Commission deputy assistant director Sara Razi suggested that the Court’s decision, made last February, strengthened federal antitrust lawyers when clarifying when state antitrust law can trump federal; the Court unanimously agreed that “state-action immunity is disfavored” in FTC vs. Phoebe Putney Health System. The FTC sued the health group over a merger, approved by Georgia’s state hospital regulators. According to Razi, the ruling was “manna from heaven” and suggested that the Court’s ruling demonstrated unity between liberals and conservatives when it comes to federal antitrust exemptions. According to Razi, this may lead to more legal action taken within the healthcare sector as federals find the support of Supreme Court precedence.
Featured News
Judge Pushes Elite College Financial Aid Antitrust Trial Toward Thanksgiving Finish
Jul 23, 2026 by
CPI
Altria, Juul Ask Appeals Court to Reverse Antitrust Class Certification
Jul 23, 2026 by
CPI
Japan Expands Antitrust Watchdog’s Role With New Bureau for Big Tech Oversight
Jul 23, 2026 by
CPI
DOJ Introduces Faster Merger Review Process With Targeted Antitrust Requests
Jul 23, 2026 by
CPI
EU Hits Google With $1 Billion Fine in First Digital Markets Act Penalty
Jul 23, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes